← Eichor
Study identifier: NCT05370079 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Control Cohort CTRL COH

Condition: Parkinson's Disease; Amyotrophic Lateral Sclerosis; Glioblastoma; Cancer Without Neurological Disease; Rheumatoid Polyarthritis  ·  Sponsor: Hospices Civils de Lyon

PhaseNA
Planned participants350
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

Autoimmune encephalitis (AE) and paraneoplastic neurological syndromes (PNS) are rare disease that could be difficult to diagnose. So it necessary to obtain numerous sample from different disease to develop more specific diagnosis kit It could be possible through the characterisation of new genetic biomarkers.

This description comes directly from the study's public registry record.

Talk to the study team

Jerome Honnorat, Pr  ·  (33) 4 72 35 78 06  ·  jerome.honnorat@chu-lyon.fr

Géraldine Picard, CRA  ·  (33) 4 72 35 58 42  ·  geraldine.picard@chu-lyon.fr

Always discuss trial participation with your own doctor first.

Locations (1)

Hospices Civils de LyonBron, FranceRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05370079